Five Cincinnati-based Startups Join Spring 2025 gBETA Accelerator
gener8tor and CincyTech welcome the gBETA Cincinnati Late Spring 2025 Cohort
Cincinnati, OH – Building on the momentum of a successful cohort earlier this year, five more local companies have joined the gBETA Cincinnati startup accelerator cohort. Timing, Ecoshell, Futureheal, MetaMol, and TestU were accepted after a competitive application process, and kicked off the 7-week program earlier this month.
gBETA Cincinnati – a program by national venture capital firm gener8tor – is a free seven-week accelerator program designed to set a path for Cincinnati startups to pursue investment opportunities. Startup founders receive intensive concierge coaching and access to gener8tor's national network of mentors, customers, corporate partners and investors.
gener8tor received applications from across Cincinnati for the program. The five selected companies were chosen based on their growth potential and investor readiness. See below for more details on each company.
“We had some great momentum with the first cohort of the year, and I’m thrilled to build on that with this next exciting cohort,” said Amory Lenarz, gBETA Cincinnati Program Manager. “These programs provide mentoring and support for Cincinnati’s best and brightest founders, boosting the local economy and community.”
The program is made possible by a partnership with CincyTech.
"Investing in young companies and novel technologies is not just funding ideas; it is fueling economic and job growth and supporting bright talent in our region," said Emma Off, Chief Executive Officer and President at CincyTech.
The startups from both 2025 cohorts will pitch their companies to investors, community partners and the public at a showcase at 4:30 p.m. on Wednesday, June 25, at the Woodward Theater, 1404 Main St., in Cincinnati. RSVP here.
Startup companies and founders interested in learning more about gBETA’s programming and resources or applying to a future program can visit the generator gBETA website, or reach out to Amory at amory@gener8tor.com. Those interested in mentoring these companies or getting involved in other ways are also encouraged to connect.
gBETA Cincinnati Late Spring 2025 Cohort
Timing’s AI agent partners with you to manage your professional relationships. It autonomously maintains up-to-date details on all your contacts and sends you personalized reminders and recommendations for maintaining those relationships, while keeping you in the driver’s seat. A job-seeker pilot is planned for this summer, and three universities are currently signed up to use Timing this fall, with 30+ in the pipeline.
Founder: Dylan Pinkins | dap157@case.edu
Ecoshell makes plastic out of eggshells to reduce plastic waste. The patented solution is market proven and fully eco-certified, providing an affordable, effective solution for companies looking to meet reduction mandates or sustainability goals, while cleaning up agriculture waste. Recently selected to attend the prestigious MassChallenge in Switzerland, Ecoshell is currently working on product or material development with 8+ multinational brands.
CEO: Andrew Bliss | andrew@ecoshell.eco
Futureheal’s flagship product, Appai, is an AI-powered decision support tool that helps analyze and identify causes of pediatric abdominal pain using validated blood markers. Appai has been clinically tested and is already being used in real-world settings. The affordable system integrates seamlessly into hospital workflows and supports physicians in decision-making; parents can also request its use for second opinions. Since 2022, 22 hospitals have tested Appai on more than 2,000 patients, and Futureheal has secured $150,000 in committed funding toward its current round.
Co-founder: Emrah Aydin | emrah.aydin@fetal.ist
MetaMol provides a diagnostic test to accurately determine breast cancer risk. Rather than being placed into imprecise risk brackets, MetaMol provides an individualized result allowing physicians to provide corresponding care. Bolstered by a TVSF grant, MetaMol will seek FDA approval for their diagnostic application, then for their therapeutic application to treat cancers that have spread to multiple organs.
CEO: Georg Weber | georg.weber@uc.edu
TestU reduces the spread of STDs by offering confidential and affordable at-home testing, thus expanding a stigmatized market. TestU targets sexually active college students and individuals in urban areas who value privacy and convenience. Product development is underway with the founding team of a PhD pharmacology student and experienced at-home health-testing startup professional.
CEO: Lance Kuo-Esser | lkuoesser@gmail.com
###
About gener8tor
gener8tor is a global venture firm and accelerator network that supports startups, workers, employers, artists and musicians across race, place and gender. gener8tor partners with companies, governments, universities and nonprofits to operate programs and conferences in more than 41 communities across 22 states and two countries. Fast Company named gener8tor one of the Best Workplaces for Innovators in 2021 and 2022. The International Trade Council recognized gener8tor as Global Venture Capital Firm of the Year in 2022.
About gBETA
gBETA is a non-equity accelerator that facilitates the growth of early-stage companies through a network-driven program. This accelerator supports five startups per cohort and requires no fees for startups and takes no equity. Since launching in 2015, gBETA accelerator alumni have raised more than $8483M in capital and created more than 5,600 jobs.
About CincyTech
CincyTech is a venture capital firm that invests in innovative founders tackling the world’s complex challenges. Their experienced team collaborates with researchers, inventors, and entrepreneurs who bring deep domain expertise and market foresight. CincyTech partners early to help transform ideas into world-class companies. Supported by Ohio Third Frontier, CincyTech is one of the Midwest’s most active seed funds.
For more information, visit gener8tor.com and cincytechusa.com.